DEF: Bausch + Lomb Reports Strong 2024 Revenue Growth, Focuses on Innovation

Bausch + Lomb achieved impressive results in 2024, marked by 16% reported revenue growth and a 17% constant currency revenue increase, driven by successful product launches and leadership in key categories.

Summary

• Bausch + Lomb's 2024 was characterized by a strong emphasis on sales and operational excellence, leading to significant revenue growth.
• The company reported a 16% increase in revenue and a 17% increase in constant currency revenue for the full year.
• This growth was supported by the successful launch of new products and strengthened leadership in key areas, including dry eye solutions.
• Bausch + Lomb also enhanced its R&D capabilities and pipeline, positioning itself for both short-term and long-term success.
• The company's Annual Meeting of Shareholders will be held virtually on May 21, 2025, at 10:30 a.m. EDT.
• Shareholders are encouraged to vote on the election of ten directors, executive compensation, and the appointment of PricewaterhouseCoopers LLP as the company's auditor.
• The record date for the Annual Meeting is March 24, 2025.
• The Board recommends voting FOR all director nominees, the advisory vote on executive compensation, and the appointment of PricewaterhouseCoopers LLP as auditor.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth and strategic initiatives. While there is a mention of a net loss, the overall tone is optimistic due to the company's focus on innovation and operational excellence.

Positives

• Strong revenue growth of 16% reported and 17% constant currency.
• Successful new product launches and strengthened market leadership.
• Enhanced R&D capabilities and pipeline.
• High shareholder support (95%) for the executive compensation program.
• Implementation of shareholder-friendly compensation practices.
• Increased safety observation and near miss reporting.

Negatives

• GAAP Net Loss of ($317M).

Risks

• The document includes a cautionary note regarding forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially.
• These risks and uncertainties are discussed in Bausch + Lomb's filings with the SEC and the CSA.

Future Outlook

The company looks forward to accelerating progress in 2025, supported by its talented colleagues around the world.

Management Comments

• 2024 was defined by a relentless focus on selling and operational excellence, with impressive results that support our strategy.
• We delivered 16 percent reported revenue growth and 17 percent constant currency revenue growth for the full year thanks to seamless execution of new product launches and strengthening leadership in key categories including dry eye.
• We also significantly enhanced R&D capabilities and reloaded our pipeline, positioning the company for success in the nearand long-term.
• Innovation is once again core to who we are.

Industry Context

The announcement reflects a focus on growth and innovation, aligning with broader trends in the eye health industry where companies are investing in new products and technologies to address unmet patient needs.

Comparison to Industry Standards

• The document mentions Alcon Inc. (ALC), Align Technology, Inc. (ALGN), and The Cooper Companies, Inc. (COO) as part of its peer group.
• These companies are also major players in the eye care and medical device industries.
• Bausch + Lomb's revenue growth of 16% is a strong indicator of its performance compared to industry standards.
• The document also mentions that the company outperformed peers with respect to organic revenue growth across all segments driven by growth in Lumify, dry eye, and eye vitamins in vision care, shift to premium IOLs in surgical, and $172M Miebo revenue in pharma.

Related Party Transactions

• In April 2025, the Company terminated an arrangement with its controlling shareholder, BHC, providing for an indemnification by BHC of the Company with respect to certain indebtedness under the Master Separation Agreement.
• BHC paid the Company $14.7 million to offset such indebtedness (including principal and interest to maturity).

Stakeholder Impact

• Shareholders: The company's performance and governance practices directly impact shareholder value and voting rights.
• Employees: The company's compensation policies and practices affect employee motivation and retention.
• Customers: The company's focus on innovation and product development aims to improve customer outcomes.
• Suppliers: The company's supply chain management and sustainability initiatives impact its relationships with suppliers.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• Attend Bausch + Lomb's Annual Meeting of Shareholders on Wednesday, May 21, 2025, at 10:30 a.m. EDT.

Key Dates

Keywords

Bausch + Lomb, Annual Meeting, Shareholders, Revenue Growth, Executive Compensation, Board of Directors, Auditor, PricewaterhouseCoopers, Corporate Governance, Proxy Statement